VICTORIS
Budget Express 2026

co-presented by

  • LIC
  • JIO BlackRock

ASSOCIATE SPONSORS

  • Sunteck
  • SBI
  • Emirates
  • Dezerv
Loans
Loans

Lekha Badlani

Research Analyst

Money Control

Bosch: Steady Q3 FY26; valuation limits upside

BUSINESS

Bosch: Steady Q3 FY26; valuation limits upside

The company continues to strengthen its position in the mobility and industrial technology segments. It is expanding its product portfolio, with a focus on EV-related components and advanced electronics

Max Healthcare: Q3 softness doesn’t cloud long-term growth thesis

BUSINESS

Max Healthcare: Q3 softness doesn’t cloud long-term growth thesis

The company offers strong medium-term revenue visibility, underpinned by a large pipeline of bed additions and sustained strength in core operating metrics

Transport Corporation of India: Stable Q3, modest outlook

BUSINESS

Transport Corporation of India: Stable Q3, modest outlook

The company is well-positioned to benefit from the secular tailwinds in the logistics sector, and its planned capacity augmentation should support incremental volume growth and gradual market share gains

Gabriel India Q3 FY26: Strong execution; growth potential priced in

BUSINESS

Gabriel India Q3 FY26: Strong execution; growth potential priced in

The company has secured multiple new programmes during the quarter. These wins reinforce Gabriel’s long-established position with marquee OEMs and strengthen its near-term revenue visibility.

Subros Q3 FY26: EV readiness improves, near-term catalysts limited

BUSINESS

Subros Q3 FY26: EV readiness improves, near-term catalysts limited

The company is now positioning itself to capture the next leg of growth from electric mobility where thermal management content per vehicle structurally increases

Concor puts up a steady Q3 amid transient headwinds

BUSINESS

Concor puts up a steady Q3 amid transient headwinds

The company's business moat and solid fundamentals ensure strong long-term growth potential

Union Budget 2026 – How does E2E Networks stand to gain?

BUSINESS

Union Budget 2026 – How does E2E Networks stand to gain?

An indirect beneficiary that could gain from the positive sentiment in India data centre services

E2E Networks: Strong results; turnaround underway

BUSINESS

E2E Networks: Strong results; turnaround underway

Rising AI demand, stricter data-localisation norms augur well for domestic cloud infrastructure providers

Shadowfax Technologies IPO: Delivering returns or just another parcel of risk?

BUSINESS

Shadowfax Technologies IPO: Delivering returns or just another parcel of risk?

The company has solidified its presence in the parcel delivery market through a capital-efficient business model

Can the Union Budget lift sentiment for rural India?

BUSINESS

Can the Union Budget lift sentiment for rural India?

Sustained rural growth is critical for India’s broader economic momentum and relying on incentives alone will not be enough

How will stocks react in the event of an El Niño?

BUSINESS

How will stocks react in the event of an El Niño?

There is a growing probability of El Niño developing from April 2026, coinciding with India’s southwest monsoon

Landmark Cars: Transition pains behind, growth momentum builds up

BUSINESS

Landmark Cars: Transition pains behind, growth momentum builds up

The October-December quarter gathers pace with a double-digit YoY growth in passenger vehicle sales

Discovery Series: E2E Networks: Riding India’s AI compute supercycle

BUSINESS

Discovery Series: E2E Networks: Riding India’s AI compute supercycle

Rising AI demand, stricter data-localisation norms augur well for domestic cloud infrastructure providers

Park Medi World IPO: Is it the right spot to park your money?

BUSINESS

Park Medi World IPO: Is it the right spot to park your money?

Over the years, PMWL has undertaken a series of acquisitions, acquiring 8 hospitals across North India. The company follows a cluster-based approach to grow its network to drive operational synergies

NephroPlus IPO: Is this single-speciality healthcare player worth a look?

BUSINESS

NephroPlus IPO: Is this single-speciality healthcare player worth a look?

India’s largest dialysis service provider and the only domestic player has scaled up internationally

Krsnaa Diagnostics: Steering towards new growth horizons

BUSINESS

Krsnaa Diagnostics: Steering towards new growth horizons

The company is targeting 40-50% of revenue mix from its retail business

Does this auto ancillary stock merit a place in your portfolio?

BUSINESS

Does this auto ancillary stock merit a place in your portfolio?

CAL’s aluminium business remains a key growth driver aided by acquisitions of DR Axion and Sunbeam

Excelsoft IPO: Is this SaaS play worth a subscription?

BUSINESS

Excelsoft IPO: Is this SaaS play worth a subscription?

The company is well placed to benefit from the digitisation tailwinds in the education sector

Max Healthcare Q2 FY26: Improved valuation comfort

BUSINESS

Max Healthcare Q2 FY26: Improved valuation comfort

The company plans to double its capacity in 4-5 years

Endurance Technology Q2 FY26: Multiple catalysts at work

BUSINESS

Endurance Technology Q2 FY26: Multiple catalysts at work

The company is leveraging structural industry shifts, regulatory changes, and strategic partnerships to drive growth

Suraksha Diagnostics Q2 FY26: Offering a long-term investment case

BUSINESS

Suraksha Diagnostics Q2 FY26: Offering a long-term investment case

It is a scalable play on India’s evolving healthcare demand

Global Health Q2 FY26: Healthy performance, strong outlook

BUSINESS

Global Health Q2 FY26: Healthy performance, strong outlook

The upcoming greenfield projects will help Medanta to establish a presence in western and eastern India

Apollo Hospitals: Q2 numbers in good health

BUSINESS

Apollo Hospitals: Q2 numbers in good health

Apollo is well positioned to benefit from the rising healthcare demand in India

SJS Enterprises: The earnings momentum remains strong in Q2

BUSINESS

SJS Enterprises: The earnings momentum remains strong in Q2

SJS expects to grow at 2.5x the industry volume in FY26

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347